Stocktoria
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. 600436.SS
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436.SS) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 2.84% (safety: at-risk). FY2025 revenue was CN¥9.0B at a 24.0% net margin.
About Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
Zhangzhou Pientzehuang Pharmaceutical., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals under the Pien Tze Huang brand name. It is also involved in the sale of food; production of skin, hair, and oral care daily products; biotechnology and medical device research and development; sale of medical machinery; and online wholesale and retail. The company's products are used for liver diseases, cardiovascular and cerebrovascular, cancer, cold, dermatology, and other applications. It exports its products. The company was founded in 1956 and is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd. operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
How it ranks in Healthcare · percentile among 73 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.487 |
| Retained earnings / assets | 0.605 |
| EBIT / assets | 0.128 |
| Equity / liabilities | 5.882 |
FAQ
Is 600436.SS financially healthy?
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 600436.SS pay a dividend, and is it safe?
Yes. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. pays a dividend yielding about 2.84% with a 91.2% payout ratio, rated “at-risk” for safety.
How profitable is 600436.SS?
In FY2025, Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. had a net margin of 24.0% and a return on equity of 14.8%.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.